We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biotech and Biomed Researchers to Benefit from Imaging Companies Merger

By LabMedica International staff writers
Posted on 23 Mar 2010
The integration of two highly regarded manufacturers of imaging and microscopy systems is designed to provide scientists and clinicians in the biomedical and biotechnical fields with the best options for imaging and intelligent image analysis.

The actors in this endeavor are Leica Microsystems (Wetzlar, Germany), which has acquired Genetix Ltd. More...
(New Milton, United Kingdom).

Leica Microsystems is a leading global designer and producer of innovative, high technology, precision optical systems for the analysis of microstructures. It is a market leader in the fields of microscopy, confocal laser scanning microscopy, and corresponding imaging systems, specimen preparation and medical equipment.

Genetix has established industry standards in areas such as picking microbial colonies for genomic studies or screening and selection of mammalian cell lines. Other Genetix systems use imaging platforms to monitor cell growth, evaluate cellular response, and quantify tissue biomarkers. Genetix will exist as a separate business unit within Leica Microsystems and will continue to market its products through existing channels. Customer services such as product ordering, applications support, and instrument service will remain unchanged.

Stefan Traeger, managing director of the life science division at Leica Microsystems, said, "Genetix's extensive expertise will be invaluable for us. Their software capabilities, specifically in analytical software, will help us to make progress in the area of virtual microscopy, which is a field we have only recently stepped into. In addition, Genetix's experience and market leading products in cell biology and genetics will expand our reach into the drug discovery and development markets.”

Charles de Rohan, head of the Genetix business unit within Leica Microsystems, said,
"Joining together with Leica Microsystems gives Genetix greater access to global markets and increased financial resources to achieve its growth plans. Over the past decade, Genetix has been building its presence in the life sciences, diagnostics, and digital pathology segments through a combination of internal product development and acquisitions. Combining our strengthening presence with Leica Microsystems' R&D capabilities, greater resources, and global reach is in the best interests of our shareholders, customers, and employees and will maximize the potential of our innovative technology.”

Related Links:
Leica Microsystems
Genetix Ltd.



New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.